References
- Jiang S, Zhao R, Li Y, Han X, Liu Z, Ge W, et al. Prognosis and nomogram for predicting postoperative survival of duodenal adenocarcinoma: a retrospective study in China and the SEER database. Sci Rep. 2018; 8(1):7940.
- Lu Y, Fröbom R, Lagergren J. Incidence patterns of small bowel cancer in a population-based study in Sweden: increase in duodenal adenocarcinoma. Cancer Epidemiol. 2012;36(3):e158–e163. doi:10.1016/j.canep.2012.01.008.
- Bojesen RD, Andersson M, Riis LB, Nielsen OH, Jess T. Incidence of, phenotypes of and survival from small bowel cancer in Denmark, 1994-2010: a population-based study. J Gastroenterol. 2016;51(9):891–899.
- Zhang S, Cui Y, Zhong B, Xiao W, Gong X, Chao K, Chen M. Clinicopathological characteristics and survival analysis of primary duodenal cancers: a 14-year experience in a tertiary centre in South China. Int J Colorectal Dis. 2011;26(2):219–226.
- Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009;249(1):63–71.
- Caraşca C, Simion G, Nechifor-Boilă AC, Boeriu AM, Dobru ED. A rare case of signet-ring cell carcinoma associated with poorly differentiated adenocarcinoma of the non-ampullary duodenum. Rom J Morphol Embryol. 2018;59(1):311–315.
- Buchbjerg T, Fristrup C, Mortensen MB. The incidence and prognosis of true duodenal carcinomas. Surg Oncol. 2015;24(2):110–116. doi:10.1016/j.suronc.2015.04.004.
- Kim MJ, Choi SB, Han HJ, Park PJ, Kim WB, Song TJ, et al. Clinicopathological analysis and survival outcome of duodenal adenocarcinoma. Kaohsiung J Med Sci. 2014;30(5):254–259.
- Lim YJ, Kim K. Effect of postoperative radiotherapy on survival in duodenal adenocarcinoma: a propensity score-adjusted analysis of surveillance, epidemiology, and end results database. Int J Clin Oncol. 2018;23(3):473–481.
- Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) Program. Oncologist. 2007;12(1):20–37. doi:10.1634/theoncologist.12-1-20.
- Coupland VH, Kocher HM, Berry DP, Allum W, Linklater KM, Konfortion J, et al. Incidence and survival for hepatic, pancreatic and biliary cancers in England between 1998 and 2007[J. Cancer Epidemiol. 2012;36(4):e207–e214. doi:10.1016/j.canep.2012.03.010.
- Ryder NM, Ko CY, Hines OJ. Primary duodenal adenocarcinoma: a 40-year experience. Arch Surg. 2000;135(9):1070–1074. discussion 1074-5. doi:10.1001/archsurg.135.9.1070.
- Zenali M, Overman MJ, Rashid A, Broaddus RB, Wang H, Katz MH, et al. Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma. Hum Pathol. 2013;44(12):2792–2798.
- Gibbs JF. Duodenal adenocarcinoma: is total lymph node sampling predictive of outcome?. Ann Surg Oncol. 2004;11(4):354–355. doi:10.1245/ASO.2004.02.914.
- Ecker BL, McMillan MT, Datta J, Dempsey DT, Karakousis GC, Fraker DL, et al. Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: a matched cohort study. Eur J Cancer (Oxford, England: 1990). 2016;69:135–141. doi:10.1016/j.ejca.2016.09.027.
- Mann K, Gilbert T, Cicconi S, Jackson R, Whelan P, Campbell F, et al. Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma. Langenbecks Arch Surg. 2019;404(4):439–449. doi:10.1007/s00423-019-01779-w.
- Poultsides GA, Huang LC, Cameron JL, Tuli R, Lan L, Hruban RH, et al. Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment. Ann Surg Oncol. 2012;19(6):1928–1935.
- Jiang Q-L, Huang X-H, Chen Y-T, Zhang J-W, Wang C-F. Prognostic factors and clinical characteristics of patients with primary duodenal adenocarcinoma: a single-center experience from China. BioMed Res Int. 2016;2016:1–6.
- Ecker BL, McMillan MT, Datta J, Lee MK, Karakousis GC, Vollmer CM, et al. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: a propensity score-matched analysis of a nationwide clinical oncology database. Cancer. 2017;123(6):967–976.